Evidence map›Paper›PMID 24085304›Full record

ArticleThe Journal of biological chemistry2013

Elongation factor-1α is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum.

Makoto Matsubayashi, Isao Teramoto-Kimata, Shigehiko Uni, Hyun S Lillehoj, Haruo Matsuda, Masaru Furuya, Hiroyuki Tani, Kazumi Sasai

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Evaluation of Immunoprotective Effects of DNA Vaccine Based onAnimals : an open access journal from MDPI · 2026
    Article
  2. Comparative Analysis of the EF-1α Intergenic Region inInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. RNA-Seq of Phenotypically DistinctPathogens (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Protection againstInfection and immunity · 2023
    Article
  7. Article
  8. Article
  9. Proteomic Analysis ofPathogens (Basel, Switzerland) · 2022
    Article
  10. An Ebola,Computational and structural biotechnology journal · 2021
    Article
  11. Evaluation on Elongation Factor 1 Alpha ofPathogens (Basel, Switzerland) · 2020
    Article
  12. Article
  13. Review
  14. Differential Expression of ThreeFrontiers in microbiology · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Makoto MatsubayashiDepartment of Food and Nutrition, Osaka Yuhigaoka Gakuen Junior College, Tennoji-ku, Osaka 543-0073, Japan; Bacterial and Parasitic Disease Research Division, National Institute of Animal Health, National Agricultural and Food Research Organization, Tsukuba, Ibaraki 305-0856, Japan.
Isao Teramoto-KimataDepartment of Parasitology, Graduate School of Medicine, Osaka City University, Abeno-ku, Osaka 545-8585, Japan.
Shigehiko UniDepartment of Parasitology, Graduate School of Medicine, Osaka City University, Abeno-ku, Osaka 545-8585, Japan; Institute of Biological Sciences, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Hyun S LillehojUnited States Department of Agriculture, Animal Biosciences and Biotechnology Laboratory, Beltsville Agricultural Research Center, Beltsville, Maryland 20705.
Haruo MatsudaLaboratory of Immunobiology, Department of Molecular and Applied Biosciences, Graduate School of Biosphere Sciences, Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8528, Japan.
Masaru FuruyaDepartment of Veterinary Internal Medicine, Division of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Osaka 598-8531, Japan.
Hiroyuki TaniDepartment of Veterinary Internal Medicine, Division of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Osaka 598-8531, Japan.
Kazumi SasaiDepartment of Veterinary Internal Medicine, Division of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Osaka 598-8531, Japan. Electronic address: ksasai@vet.osakafu-u.ac.jp.
Osaka Prefecture University · JPOsaka City University · JPHiroshima University · JPNational Agriculture and Food Research Organization · JPUnited States Department of Agriculture · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The phylum Apicomplexa comprises obligate intracellular parasites that infect vertebrates. All invasive forms of Apicomplexa possess an apical complex, a unique assembly of organelles localized to the anterior end of the cell and involved in host cell invasion. Previously, we generated a chicken monoclonal antibody (mAb), 6D-12-G10, with specificity for an antigen located in the apical cytoskeleton of Eimeria acervulina sporozoites. This antigen was highly conserved among Apicomplexan parasites, including other Eimeria spp., Toxoplasma, Neospora, and Cryptosporidium. In the present study, we identified the apical cytoskeletal antigen of Cryptosporidium parvum (C. parvum) and further characterized this antigen in C. parvum to assess its potential as a target molecule against cryptosporidiosis. Indirect immunofluorescence demonstrated that the reactivity of 6D-12-G10 with C. parvum sporozoites was similar to those of anti-β- and anti-γ-tubulins antibodies. Immunoelectron microscopy with the 6D-12-G10 mAb detected the antigen both on the sporozoite surface and underneath the inner membrane at the apical region of zoites. The 6D-12-G10 mAb significantly inhibited in vitro host cell invasion by C. parvum. MALDI-TOF/MS and LC-MS/MS analysis of tryptic peptides revealed that the mAb 6D-12-G10 target antigen was elongation factor-1α (EF-1α). These results indicate that C. parvum EF-1α plays an essential role in mediating host cell entry by the parasite and, as such, could be a candidate vaccine antigen against cryptosporidiosis.

Indexed as

AnimalsAntibodies, ProtozoanAntigens, ProtozoanCell Line, TumorCell MembraneCryptosporidiosisCryptosporidium parvumMaleMiceMice, SCIDPeptide Elongation Factor 1Protozoan ProteinsProtozoan VaccinesSporozoitesAntibodies, ProtozoanAntigens, ProtozoanPeptide Elongation Factor 1Protozoan ProteinsProtozoan VaccinesCell-penetrating PeptidesCytoskeletonElectron Microscopy (EM)ProtozoanTranscription Elongation FactorsTranslation Elongation FactorsWestern Blotting

Identifiers

PMID24085304
PMCPMC3837153
OpenAlexW1979192513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.